Skip to main content

Closed

IMDX: Insight Molecular Diagnostics Inc. Stock Analysis | finqOS

Healthcare · Medical - Diagnostics & Research

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-2112.4%

ROIC-136.4%

Financially safe

Stretched

Debt / equity-0.29×

Interest coverage-399.7×

Current ratio2.54×

Insight Molecular Diagnostics Inc.

IMDXNASDAQ Capital Market·USD·Closed

Insight Molecular Diagnostics Inc.

IMDXNASDAQ·USD·Closed

$4.65

+1.09%

$4.65

+$0.05 (1.09%)

52W Range

38thpctl

Volume

0.20×avg

Mkt Cap

150.15MUSD

P/E

-3.1TTM

Div Yield

–ann

52W Range

38thpctl

Volume

0.20×avg

Market Cap

150.15MUSD

P/E Ratio

-3.1TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings